retatrutide clinical trial results weight loss Results: How Much Can You Lose & How Quick? retatrutide clinical trial data Eli

Following the surge in demand for GLP-1s such as tirzepatide, semaglutide (and retatrutide anticipated in the near future) for diabetes and weight management, compounded versions of GLP-1s have proliferated online and through telehealth platforms

However, Ozempic is not an approved drug for weight loss despite people taking it for that purpose, instead you should be taking Wegovy or one of the other approved weight loss drugs available on prescription such as Mounjaro

Tachycardia Most patients see at least some heart rate increase on GLP-1 drugs, but some studies have shown significant jumps into the range of tachycardia

In the SURMOUNT-1 trials, the tirzepatide group lost about 20.2% of baseline body weight in 72 weeks, while the semaglutide group lost about 13.7 %

Patients currently on Saxenda may want to discuss alternative options with their doctor as supply winds down